ELLEN NEU: Open Payments
NPI 1942465000 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 35 payments from 9 companies in 2025. Trend: 2023 $23 · 2024 $439 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $376 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $219 |
| Novo Nordisk Inc | 3 | $139 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Lilly USA, LLC | 3 | $51 |
| Amgen Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Grifols USA, LLC | 1 | $20 |
| Edwards Lifesciences Corporation | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, Ozempic, MOUNJARO, AIRSUPRA, KRYSTEXXA, BREZTRI, GEMTESA.
Industry payments across NC — which companies pay providers there.
